[The use of calcium antagonists in the treatment of ocular circulation symptoms in the framework of a vasospastic syndrome]
- PMID: 3363311
[The use of calcium antagonists in the treatment of ocular circulation symptoms in the framework of a vasospastic syndrome]
Abstract
In a number of patients with etiologically unexplained visual field loss, a vasospastic syndrome was found with the aid of capillaroscopic local cooling test on the fingers. After therapy with calcium entry blockers the visual field of the patients with vasospastic syndrome underwent a marked and statistically significant improvement. The control group showed a slight but statistically insignificant tendency towards improvement.
Similar articles
-
Vasospastic transient monocular visual loss: effect of treatment with different doses of nifedipine.J Neuroophthalmol. 2014 Dec;34(4):386-8. doi: 10.1097/WNO.0000000000000144. J Neuroophthalmol. 2014. PMID: 24905274
-
Treatment of digital vasospastic disease with the calcium-entry blocker nifedipine.Acta Med Scand. 1984;215(2):135-9. doi: 10.1111/j.0954-6820.1984.tb04983.x. Acta Med Scand. 1984. PMID: 6702493
-
Influence of vasospasm on visual function.Doc Ophthalmol. 1987 May;66(1):3-18. doi: 10.1007/BF00144735. Doc Ophthalmol. 1987. PMID: 3322745 Review.
-
Vascular response of Raynaud's phenomenon to nifedipine or herbal medication (duhuo-tisheng tang with danggui-sini tang): a preliminary study.Chang Gung Med J. 2008 Sep-Oct;31(5):492-502. Chang Gung Med J. 2008. PMID: 19097597
-
Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis.Rheumatology (Oxford). 2005 Feb;44(2):145-50. doi: 10.1093/rheumatology/keh390. Epub 2004 Nov 16. Rheumatology (Oxford). 2005. PMID: 15546967 Review.
Cited by
-
Ocular vasospasm: a risk factor in the pathogenesis of low-tension glaucoma.Int Ophthalmol. 1989 Jul;13(4):281-90. doi: 10.1007/BF02280088. Int Ophthalmol. 1989. PMID: 2693385 Review.
-
Why study vascular factors in glaucoma?Int Ophthalmol. 1998-1999;22(4):221-5. doi: 10.1023/a:1006294824980. Int Ophthalmol. 1998. PMID: 10674866 Review.
-
The discovery of the Flammer syndrome: a historical and personal perspective.EPMA J. 2017 May 22;8(2):75-97. doi: 10.1007/s13167-017-0090-x. eCollection 2017 Jun. EPMA J. 2017. PMID: 28725290 Free PMC article. Review.
-
The primary vascular dysregulation syndrome: implications for eye diseases.EPMA J. 2013 Jun 7;4(1):14. doi: 10.1186/1878-5085-4-14. EPMA J. 2013. PMID: 23742177 Free PMC article.
-
Short-term effect of dipyridamole on blood flow velocities in the extraocular vessels.Int Ophthalmol. 1995-1996;19(6):355-8. doi: 10.1007/BF00130854. Int Ophthalmol. 1995. PMID: 8970869 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical